Problem
COVID-19 vaccine hesitancy has been recognized as a problem across nations. In some of the world’s poorest nations, where vaccine access issues are being gradually resolved, a resistance to getting vaccinated is emerging as a major hurdle. Scientists fear that persistent pools of unvaccinated people around the world will present a greater risk for the emergence of new variants of concern, like Omicron. Addressing people’s hesitancy is therefore crucial to curb the spread of COVID-19, and to consequently avert hospitalizations and death.
Objectives
We aim to understand why people are hesitant about getting the COVID-19 vaccine. Hesitancy could not only occur within the unvaccinated population but also in a subset of people who already got vaccinated. Therefore, phase 1 of the project has the following objectives:
Approach
We intend to use chatbot as a medium (on Facebook) to conduct conversations with people to understand how we can best achieve the above three objectives. We have run five pilots as of August 30 2022, – 2 in the United States using Qualtrics on Lucid, and 3 in South Africa on Facebook. The eventual goal will be running this using multiple chatbots that enable the conversation to flow more naturally than in a survey format.
We hypothesize that respondents are more likely to respond to our sensitive questions around vaccine hesitancy if the questions are asked more casually in an open stress-free setting. Therefore, in all version of the pilots, we make our tone as causal as possible (using emojis, GIFs, emphatic prompts) and include delays in the appearance of questions (and empathetic responses after each question) to make the conversation more authentic.
This analysis is based on 4351 respondents who completed the current pilot survey wave and are randomized. We aim to compare the performance across four different themes (fear, unnecessary, risky, inaccessible) for each target audience (Ghana, Kenya, Nigeria, South Africa, South Africa - lookalike), built upon hypothesized drivers of hesitancy, as well as different versions of creative within those themes.
Learning Goal: To come away with descriptive segments and generalizable findings about the effectiveness of treatments on those segments, we’d ideally randomly the same population for the duration of our study.
Viability Goal: We will need to drive for the lowest possible cost per participants in order to collect as many responses as possible within our budget. Our past pilots have relied on Facebook’s optimization to make progress towards this goal.
Setting Principle:
Ad Performance will be measured using the following indicators:
Detailed setting for Pilot v8 can be found here.
fear, 30 inaccessible, 30 risky, 30 unnecessary)Ghana, 21 Kenya, 21 Nigeria, 21 South Africa, and 21 South Africa-lookalike)The ad analysis contains 3 tables using different combinations of 15 distinct ads:
Metrics explanation:
Impressions (Total Count) = the total number of times our ad has been viewedClickthrough (%) = #clicks / #impressionsMessages Sent (%) = #conversations / #clicksConsent Obtained (%) = #consents / #conversationsCore Survey Complete (%) = #forking section completed / #consentsTreatment Complete (%) = #treatment section completed / #forking section completedDemo Questions Complete (%) = #demog section completed / #treatment section completedFull Survey Complete (%) = #full chat completed / #demog section completedTotal characters elicited per completed survey (treatment) = average #character in best treatment explanation per full chat completedAvg characters elicited per completed survey (impediment explanations) = average #character in impediment explanations per full chat completedCost per Impression = amount spent / #impressions (in USD)Cost per Link Click = amount spent / #clicks (in USD)Cost per Survey Complete (All participants) = amount spent / #full chat completed (in USD)Cost per Survey Complete (Unvax) = amount spent / #full chat completed with unvaccinated participants (in USD) Country Accuracy(only for country-wise split analysis) = #users that entered survey from correct country/ #users that entered survey through the country-specific adsThis table compared four Ad impediment sources (vaccine is fearful vs vaccine is risky vs vaccine is unnecessary vs vaccine is inaccessible) in terms of the metrics described above.
This table compared 5 targeting audience - South Africa-lookalike vs South Africa vs Kenya vs Nigeria vs Ghana - in terms of the metrics described above.
This table compared nine images (provided below the table) in terms of the metrics described above. Note: 2 Image5 Ads failed to run; 1 Image9 Ad failed to run, 5 Image2 Ads failed to run, 24 Image1 Ads been rejected by FB in the second wave.
1. Almost all ads with image 1 have been rejected by Facebook in the second wave of this campaign. It may be because it has a “thumbs up” button on the image
\(~\)Next Steps:
2. South Africa-lookalike Ads have a higher cost in making impressions from Fb Ads Manager, but it has better funnel performance and lower cost in recruiting unvaccinated people than normal South Africa ads ($3.373 vs $3.52).
\(~\)Next Steps:
3. The new theme, fear, has the highest cost per survey complete (unvax) with average funnel performance
\(~\)Next Steps:
4. Ads targeting Ghana have the lowest clickthrough rate, worse funnel performance, and higher cost than the other two new countries.
\(~\)Next Steps: